SBC Medical Group Holdings Incorporated (SBC) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

+7.4%

$5.70

vs $5.31 price

Levered DCF

$3.83

After debt service

Piotroski score

6 / 9

Average

Altman Z-score

5.06

Safe zone

Rating

A+

Overall 5 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022
P/E	8.62×	11.58×	25.64×	162.68×
P/B	1.79×	2.75×	7.14×	1.46×
P/S	2.56×	2.61×	5.24×	0.88×
EV / EBITDA	3.91×	5.49×	10.88×	3.98×
Gross margin	73.3%	76.0%	70.9%	65.9%
Operating margin	38.9%	34.2%	36.5%	11.6%
Net margin	29.4%	22.7%	20.3%	3.6%
Current ratio	3.78×	3.01×	1.79×	1.12×
Debt / equity	0.21×	0.06×	0.16×	0.15×
Interest coverage	420.26×	2,484.23×	1,560.1×	639.85×
Dividend yield	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022
Return on equity	20.5%	23.9%	27.7%	6.0%
Return on invested capital	12.6%	21.3%	21.3%	3.6%
Return on assets	13.4%	17.5%	15.2%	2.8%
Free cash flow yield	8.2%	3.2%	3.9%	-16.3%
Earnings yield	11.5%	8.7%	3.9%	4.1%
Enterprise value	$331.8M	$424M	$934.3M	$118.1M
Net debt / EBITDA	-1.32×	-1.46×	-0.93×	-1.2×
Cash conversion cycle (days)	-5	-11	-52	6